Mouse Monoclonal TLR5 Antibody (19D759.2)
Applications | Dot, FC, ICC/IF, IHC, IP, WB |
Reactivities | Human, Mouse, Canine |
Mouse Monoclonal TLR5 Antibody (19D759.2)
Applications | Dot, FC, ICC/IF, IHC, IP, WB |
Reactivities | Human, Mouse, Canine |
TLR5 CRISPRa kit - CRISPR gene activation of human toll like receptor 5
Format | 3 gRNAs (5ug each), 1 scramble ctrl (10ug) and 1 enhancer vector (10ug) |
Tlr5 CRISPRa kit - CRISPR gene activation of mouse toll-like receptor 5
Format | 3 gRNAs (5ug each), 1 scramble ctrl (10ug) and 1 enhancer vector (10ug) |
TLR5 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector, 5µg of each construct provided
Format | Lentiviral plasmids |
Vector | pGFP-C-shLenti |
qSTAR qPCR primer pairs against Mus musculus gene Tlr5
Purified recombinant protein of Mouse toll-like receptor 5 (Tlr5), with C-terminal MYC/DDK tag, expressed in HEK293T cells, 20ug
Tag | C-MYC/DDK |
Expression Host | HEK293T |
Transient overexpression of TLR5 in HEK293T cells, FFPE control for IHC, ICC and ISH staining, 25 slides per pack
Tlr5 - Mouse, 4 unique 29mer shRNA constructs in retroviral untagged vector, 5µg of each construct provided
Format | Retroviral plasmids |
Vector | pRS |
Tlr5 - Rat, 4 unique 29mer shRNA constructs in retroviral untagged vector, 5µg of each construct provided
Format | Retroviral plasmids |
Vector | pRS |
Tlr5 - Mouse, 4 unique 29mer shRNA constructs in lentiviral GFP vector, 5µg of each construct provided
Format | Lentiviral plasmids |
Vector | pGFP-C-shLenti |
Tlr5 - Rat, 4 unique 29mer shRNA constructs in lentiviral GFP vector, 5µg of each construct provided
Format | Lentiviral plasmids |
Vector | pGFP-C-shLenti |
Mouse Monoclonal TLR5 Antibody (85B152.5)
Applications | FC, IHC, WB |
Reactivities | Human, Mouse, Canine |
TLR5 rabbit polyclonal antibody
Applications | IHC |
Reactivities | Human |
TLR5 rabbit polyclonal antibody
Applications | IHC |
Reactivities | Human |
TLR5 rabbit polyclonal antibody, Purified
Applications | IHC, WB |
Reactivities | Human, Mouse, Rat |